Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Toxicol Lett ; 295: 99-114, 2018 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-29908848

RESUMEN

Tributyltin chloride (TBT) is an obesogen associated with various metabolic and reproductive dysfunctions after in utero exposure. However, few studies have evaluated TBT's obesogenic effect on adult ovaries. In this study, we assessed whether TBT's obesogenic effects resulted in adult ovarian adipogenesis and other reproductive abnormalities. TBT was administered to adult female Wistar rats, and their reproductive tract morphophysiology was assessed. We further assessed the ovarian mRNA/protein expression of genes that regulate adipogenesis. Rats exposed to TBT displayed abnormal estrous cyclicity, ovarian sex hormone levels, ovarian follicular development and ovarian steroidogenic enzyme regulation. Rats exposed to TBT also demonstrated abnormal ovarian adipogenesis with increased cholesterol levels, lipid accumulation, and PPARγ, C/EBP-ß and Lipin-1 expression. A negative correlation between the ovarian PPARγ expression and aromatase expression was observed in the TBT rats. Furthermore, TBT exposure resulted in reproductive tract atrophy, inflammation, oxidative stress and fibrosis. Ovarian dysfunctions also co-occurred with the uterine irregularities. Abnormal ovarian adipogenic markers occurring after TBT exposure may be associated with uterine irregularities. A positive correlation between the ovarian cholesterol levels and uterine inflammation was observed in the TBT rats. These findings suggest that TBT leads to ovarian obesogenic effects directly by abnormal adipogenesis and/or indirectly through adult reproductive tract irregularities.


Asunto(s)
Adipogénesis/efectos de los fármacos , Tejido Adiposo/efectos de los fármacos , Adiposidad/efectos de los fármacos , Contaminantes Ambientales/toxicidad , Obesidad/inducido químicamente , Ovario/efectos de los fármacos , Compuestos de Trialquiltina/toxicidad , Adipogénesis/genética , Tejido Adiposo/metabolismo , Tejido Adiposo/patología , Tejido Adiposo/fisiopatología , Adiposidad/genética , Animales , Atrofia , Colesterol/metabolismo , Enzima de Desdoblamiento de la Cadena Lateral del Colesterol/genética , Enzima de Desdoblamiento de la Cadena Lateral del Colesterol/metabolismo , Ciclo Estral/sangre , Ciclo Estral/efectos de los fármacos , Femenino , Fibrosis , Regulación Enzimológica de la Expresión Génica , Hormonas Esteroides Gonadales/sangre , Gotas Lipídicas/efectos de los fármacos , Gotas Lipídicas/metabolismo , Obesidad/metabolismo , Obesidad/patología , Obesidad/fisiopatología , Folículo Ovárico/efectos de los fármacos , Folículo Ovárico/metabolismo , Folículo Ovárico/patología , Ovario/metabolismo , Ovario/patología , Ovario/fisiopatología , Estrés Oxidativo/efectos de los fármacos , Enfermedad Inflamatoria Pélvica/inducido químicamente , Enfermedad Inflamatoria Pélvica/metabolismo , Enfermedad Inflamatoria Pélvica/patología , Enfermedad Inflamatoria Pélvica/fisiopatología , Fosfoproteínas/genética , Fosfoproteínas/metabolismo , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas Wistar
2.
Toxicol Appl Pharmacol ; 319: 22-38, 2017 03 15.
Artículo en Inglés | MEDLINE | ID: mdl-28161095

RESUMEN

Tributyltin chloride (TBT) is a xenobiotic used as a biocide in antifouling paints that has been demonstrated to induce endocrine-disrupting effects, such as obesity and reproductive abnormalities. An integrative metabolic control in the hypothalamus-pituitary-gonadal (HPG) axis was exerted by leptin. However, studies that have investigated the obesogenic TBT effects on the HPG axis are especially rare. We investigated whether metabolic disorders as a result of TBT are correlated with abnormal hypothalamus-pituitary-gonadal (HPG) axis function, as well as kisspeptin (Kiss) action. Female Wistar rats were administered vehicle and TBT (100ng/kg/day) for 15days via gavage. We analyzed their effects on the tin serum and ovary accumulation (as biomarker of TBT exposure), estrous cyclicity, surge LH levels, GnRH expression, Kiss action, fertility, testosterone levels, ovarian apoptosis, uterine inflammation, fibrosis, estrogen negative feedback, body weight gain, insulin, leptin, adiponectin levels, as well as the glucose tolerance (GTT) and insulin sensitivity tests (IST). TBT led to increased serum and ovary tin levels, irregular estrous cyclicity, and decreased surge LH levels, GnRH expression and Kiss responsiveness. A strong negative correlation between the serum and ovary tin levels with lower Kiss responsiveness and GnRH mRNA expression was observed in TBT rats. An increase in the testosterone levels, ovarian and uterine fibrosis, ovarian apoptosis, and uterine inflammation and a decrease in fertility and estrogen negative feedback were demonstrated in the TBT rats. We also identified an increase in the body weight gain and abnormal GTT and IST tests, which were associated with hyperinsulinemia, hyperleptinemia and hypoadiponectinemia, in the TBT rats. TBT disrupted proper functioning of the HPG axis as a result of abnormal Kiss action. The metabolic dysfunctions co-occur with the HPG axis abnormalities. Hyperleptinemia as a result of obesity induced by TBT may be associated with abnormal HPG function. A strong negative correlation between the hyperleptinemia and lower Kiss responsiveness was observed in the TBT rats. These findings provide evidence that TBT leads to toxic effects direct on the HPG axis and/or indirectly by abnormal metabolic regulation of the HPG axis.


Asunto(s)
Hormonas Hipotalámicas/metabolismo , Sistema Hipotálamo-Hipofisario/metabolismo , Kisspeptinas/metabolismo , Leptina/metabolismo , Sistema Hipófiso-Suprarrenal/metabolismo , Compuestos de Trialquiltina/toxicidad , Animales , Disruptores Endocrinos/toxicidad , Exposición a Riesgos Ambientales/efectos adversos , Ciclo Estral/efectos de los fármacos , Ciclo Estral/metabolismo , Femenino , Hormonas Hipotalámicas/antagonistas & inhibidores , Sistema Hipotálamo-Hipofisario/efectos de los fármacos , Kisspeptinas/antagonistas & inhibidores , Leptina/antagonistas & inhibidores , Obesidad/inducido químicamente , Obesidad/metabolismo , Sistema Hipófiso-Suprarrenal/efectos de los fármacos , Ratas , Ratas Wistar , Reproducción/efectos de los fármacos , Reproducción/fisiología , Transducción de Señal/efectos de los fármacos , Transducción de Señal/fisiología
3.
Hypertens Res ; 39(11): 769-776, 2016 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-27383506

RESUMEN

Renovascular hypertension is characterized by increased angiotensin II and oxidative stress, and by endothelial dysfunction. The purpose of this study was to test whether the administration of aliskiren (ALSK) and l-arginine (l-ARG) would restore impaired baroreflex sensitivity and reduce oxidative stress in a rat renovascular hypertension model. Hypertension was induced by clipping the left renal artery, and the following five groups were created: SHAM; two-kidney, 1-clip (2K1C); 2K1C plus ALSK (ALSK); 2K1C plus l-ARG (l-ARG); and 2K1C plus ALSK+l-ARG (ALSK+l-ARG). After 21 days of treatment, only the ALSK+l-ARG group was effective in normalizing the arterial pressure (108.8±2.8 mm Hg). The l-ARG and ALSK+l-ARG groups did not show hypertrophy of the left ventricle. All the treatments restored the depressed baroreflex sensitivity to values found in the SHAM group. Acute administration of TEMPOL restored the depressed baroreflex sensitivity in the 2K1C group to values that resembled those presented by the other groups. All treatments were effective for an increase in the antioxidant pathway and reduction in the oxidative pathway. In conclusion, the treatment with ALSK or l-ARG reduced oxidative stress and restored reduced baroreflex sensitivity in renovascular hypertension. In addition, the treatments were able to normalize blood pressure and reverse left ventricular hypertrophy when used in combination.


Asunto(s)
Amidas/farmacología , Arginina/farmacología , Barorreflejo/efectos de los fármacos , Fumaratos/farmacología , Hipertensión Renovascular/fisiopatología , Estrés Oxidativo/efectos de los fármacos , Sistema Nervioso Simpático/efectos de los fármacos , Animales , Presión Sanguínea/efectos de los fármacos , Catalasa/metabolismo , Frecuencia Cardíaca/efectos de los fármacos , Hipertensión Renovascular/metabolismo , Riñón/efectos de los fármacos , Riñón/metabolismo , Riñón/fisiopatología , Masculino , Ratas , Ratas Wistar , Superóxido Dismutasa/metabolismo , Sistema Nervioso Simpático/metabolismo , Sistema Nervioso Simpático/fisiopatología
4.
Reprod Toxicol ; 57: 29-42, 2015 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-26050607

RESUMEN

Organotins (OTs) are environmental contaminants used as biocides in antifouling paints that have been shown to be endocrine disrupters. However, studies evaluating the effects of OTs accumulated in seafood (LNI) on reproductive health are particularly sparse. This study demonstrates that LNI leads to impairment in the reproductive tract of female rats, as the estrous cycle development, as well as for ovary and uterus morphology. Rats were treated with LNI, and their reproductive morphophysiology was assessed. Morphophysiological abnormalities, such as irregular estrous cycles, abnormal ovarian follicular development and ovarian collagen deposition, were observed in LNI rats. An increase in luminal epithelia and ERα expression was observed in the LNI uteri. Together, these data provide in vivo evidence that LNI are toxic for reproductive morphophysiology, which may be associated with risks to reproductive function.


Asunto(s)
Disruptores Endocrinos/toxicidad , Compuestos Orgánicos de Estaño/toxicidad , Ovario/efectos de los fármacos , Alimentos Marinos/efectos adversos , Útero/efectos de los fármacos , Contaminantes Químicos del Agua/toxicidad , Animales , Colágeno/metabolismo , Disruptores Endocrinos/sangre , Disruptores Endocrinos/farmacocinética , Receptor alfa de Estrógeno/metabolismo , Receptor beta de Estrógeno/metabolismo , Ciclo Estral/efectos de los fármacos , Femenino , Contaminación de Alimentos , Gastrópodos , Compuestos Orgánicos de Estaño/sangre , Compuestos Orgánicos de Estaño/farmacocinética , Ovario/metabolismo , Ovario/patología , Ratas Wistar , Útero/metabolismo , Útero/patología , Contaminantes Químicos del Agua/sangre , Contaminantes Químicos del Agua/farmacocinética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA